Study Of The Effects Of Atorvastatin On Cholesterol Levels In Rheumatoid Arthritis Patients Taking CP-690,550
Completed · Phase 2 · Has a placebo group
Conditions studied: Rheumatoid Arthritis
In brief
All patients will be in instructed to eat a therapeutic lifestyle diet and will receive CP-690,550 throughout the 12 weeks of this study. After 6 weeks, half will receive the cholesterol lowering agent, atorvastatin, and half a matching placebo. This study will first measure the effects of CP-690,550 on cholesterol levels and then the effects of adding atorvastatin on those levels.
Key facts
- Study ID
- NCT01059864
- Run by
- Pfizer
- People needed
- 111
- Starts
- 2010-02-01
- Expected to finish
- 2010-11-01
- Last updated by the study team
- 2012-12-13
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- must be diagnosed as having active rheumatoid arthritis
- agree to participate in the study and sign and informed consent document
You may not qualify if…
- History of serious infection within the past 6 months
- test positive for TB
- have any uncontrolled clinically significant disease or laboratory tests
- require administration of prohibited medications during the study
Where it is running
- Pfizer Investigational Site — Birmingham, Alabama, United States
- Pfizer Investigational Site — Huntsville, Alabama, United States
- Pfizer Investigational Site — Gilbert, Arizona, United States
- Pfizer Investigational Site — Scottsdale, Arizona, United States
- Pfizer Investigational Site — Upland, California, United States
- Pfizer Investigational Site — Jacksonville, Florida, United States
- Pfizer Investigational Site — Dayton, Ohio, United States
- Pfizer Investigational Site — Mayfield Village, Ohio, United States
- Pfizer Investigational Site — Greenville, South Carolina, United States
- Pfizer Investigational Site — Allen, Texas, United States
- Pfizer Investigational Site — Seoul, South Korea
- Pfizer Investigational Site — Seoul, South Korea
- Pfizer Investigational Site — Seoul, South Korea
- Pfizer Investigational Site — Seoul, South Korea
- Pfizer Investigational Site — Seoul, South Korea
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.